| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2017 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 | 0.555 | 0.654 | 0.72 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
adenylate cyclase 7 | 0.656 | 0.462 | 9.5E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
adducin 1 | 0.612 | 0.615 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2017 | ||||||||
|
adrenoceptor alpha 1A | 0.462 | 0.846 | 3.4E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
adrenoceptor alpha 2B | 0.465 | 0.846 | 4.5E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
adhesion regulating molecule 1 | 0.633 | 0.538 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
afadin, adherens junction formation factor | 0.650 | 0.462 | 1.00 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 1996 | 2017 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
AF4/FMR2 family member 4 | 0.644 | 0.769 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2012 | ||||||||
|
ArfGAP with FG repeats 2 | 0.700 | 0.423 | 2.5E-04 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2007 | ||||||||
|
Abelson helper integration site 1 | 0.513 | 0.846 | 1.1E-25 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2004 | 2011 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2012 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2015 | ||||||||
|
Aicardi syndrome | 0.729 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2007 | ||||||||
|
aminoacyl tRNA synthetase complex interacting multifunctional protein 2 | 0.393 | 0.923 | 8.0E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2015 | ||||||||
|
A-kinase anchoring protein 13 | 0.626 | 0.615 | 0.93 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2005 | ||||||||
|
aldo-keto reductase family 1 member C3 | 0.529 | 0.769 | 7.6E-24 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2008 | 2009 |